| Product NDC: | 0574-0163 | 
| Proprietary Name: | Lorazepam | 
| Non Proprietary Name: | Lorazepam | 
| Active Ingredient(s): | 2 mg/mL & nbsp; Lorazepam | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | SOLUTION, CONCENTRATE | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0574-0163 | 
| Labeler Name: | Paddock Laboratories, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA079244 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20090401 | 
| Package NDC: | 0574-0163-30 | 
| Package Description: | 1 BOTTLE in 1 CARTON (0574-0163-30) > 30 mL in 1 BOTTLE | 
| NDC Code | 0574-0163-30 | 
| Proprietary Name | Lorazepam | 
| Package Description | 1 BOTTLE in 1 CARTON (0574-0163-30) > 30 mL in 1 BOTTLE | 
| Product NDC | 0574-0163 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Lorazepam | 
| Dosage Form Name | SOLUTION, CONCENTRATE | 
| Route Name | ORAL | 
| Start Marketing Date | 20090401 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Paddock Laboratories, Inc. | 
| Substance Name | LORAZEPAM | 
| Strength Number | 2 | 
| Strength Unit | mg/mL | 
| Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |